---
$id: https://graph.org.ai/products/commodity/51292014
$type: Product
source: UNSPSC
code: "51292014"
title: "Medifoxamine"
class: "51292000"
classTitle: "Antidepressant amines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Medifoxamine

**UNSPSC Code**: 51292014
**Class**: [Antidepressant amines](Antidepressant amines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin agonist and dopamine agonist with the molecular formula C16H19NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KWU7C2A1NT, chemically known as n,n-dimethyl-2,2-diphenoxyethylamine but generally known as medifoxamine, which bears US NIH Compound Identifier 36109. European Medicines Agency schedules Medifoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08693MIG. The term MEDIFOXAMINE is an International Non-Proprietary Name. World Health Organization schedules medifoxamine in its Anatomical Therapeutic Chemical (ATC) Classification. MEDIFOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medifoxamine under HS 29225000 and SITC 51467. As of Q4 2014, MEDIFOXAMINE remains the US FDA Preferred Term for this commodity. Medifoxamine bears US NLM identifiers UMLS ID C0065858 and NCI Concept Code C83914. SMILES: O(C(Oc1ccccc1)CN(C)C)c1ccccc1.

